Post-marketing Review of adverse events associated with metoclopramide
Center for Drug Evaluation and Research, FDA. 2. Purpose of Review ... Neuroleptic Malignant Syndrome (NMS); Acute dystonia; Akathisia; Parkinsonism;
Tardive dyskinesia ... Drug has been on the market for a long time; Quality of
reports ...
http://www.fda.gov/OHRMS/DOCKETS/AC/05/slides/2005-4167S1_02...
|
Knowledge creation about ADRs – turning the perspective from the ...
3FKL-Research Centre for Quality in Medicine Use, Copenhagen, Denmark ... Reports of serious ADRs that occur after marketing of the drug are discussed in
the .... Neuroleptic malignant syndrome was reported in the clinical trials with
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2291241/...
|
Tetrabenazine : Article : Nature Reviews Drug Discovery
There are no published reports of neuroleptic malignant syndrome caused by tetrabenazine, ... Box 1 | Market for antichorea therapy for Huntington's
disease ... Gibbs, L. NewCrest Biovail Research Report (New Crest, 8 Oct 2008).
...
http://www.nature.com/nrd/journal/v8/n1/full/nrd2784.html...
|
Ziprasidone in the treatment of mania in bipolar disorder
One report documented two schizoaffective patients who experienced abrupt rises .... been on the market during only 5 of the years that were studied by the
authors. .... Neuroleptic malignant syndrome and atypical antipsychotic drugs.
.... From clinical research to clinical practice: a 4-year review of ziprasidone
. ...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2656324/...
|
Video - - SPhere
Neuroleptic Malignant Syndrome (NMS): NMS, a potentially fatal symptom complex, .... Through its own biopharmaceutical research and collaborations with partners
... the commercial plans for and the potential market for SAPHRIS/SYCREST. ...
http://www.merck.com/newsroom/news-release-archive/schering-...
|
The pharmacovigilance of olanzapine: results of a post-marketing ...
Drug Safety Research Unit, Faculty of Health and Biological Sciences, ... Serious suspected adverse reactions were neuroleptic malignant syndrome ...
There were eight reports of diabetes mellitus assessed as possibly due to
olanzapine. ...
http://www.ncbi.nlm.nih.gov/pubmed/11769820...
|
Seroquel® (quetiapine fumarate) Tablets: Letter
16 Nov 2006 ... Neuroleptic Malignant Syndrome (NMS) .... adverse events associated with Seroquel based upon these reports. Therefore, quantifying ... Evaluation and
Research, Division of Drug Marketing, Advertising, and Communications, ...
http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulat...
|
Focus on Ziprasidone: A Review of its use in Child and Adolescent ...
Neuroleptic malignant syndrome has been described in an adolescent taking ziprasidone ... However, one case report was associated with an increase in
weight ... monograph of statements regarding FDA 5-year post-marketing adverse
data ..... About NCBI · Research at NCBI · NCBI Newsletter · NCBI FTP Site ·
Contact Us ...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2583921/...
|
Atypical Antipsychotics: A Practical Review: Olanzapine
Najara JE, Enikeev I: Risperidone and neuroleptic malignant syndrome. .... Clinical and Research Reports 1(2):190-192, 1989. Rosenthal SH, Fenton ML, ...
http://www.medscape.com/viewarticle/430851_3...
|
Introduction -- Drug Class Review on Atypical Antipsychotic Drugs ...
Since then, 6 other atypical antipsychotics have been brought to market: risperidone ... Subsequently, a large body of research has emerged that focuses
specifically .... For this report we sought evidence about outcomes that are
important to .... diabetic ketoacidosis, weight gain, neuroleptic malignant
syndrome, ...
http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=antipsych...
|
